ASA Suppresses PGE<sub>2</sub> in Plasma and Melanocytic Nevi of Human Subjects at Increased Risk for Melanoma

ASA Suppresses PGE<sub>2</sub> in Plasma and Melanocytic Nevi of Human Subjects at Increased Risk for Melanoma

Potential anti-inflammatory and anticarcinogenic effects of aspirin (ASA) may be suitable for melanoma chemoprevention, but defining biomarkers in relevant target tissues is prerequisite to performing randomized controlled chemoprevention trials. We conducted open-label studies with ASA in 53 human...

Full description

Bibliographic Details
Main Authors: Amir Varedi, Hafeez Rahman, Dileep Kumar, Jonathan L. Catrow, James E. Cox, Tong Liu, Scott R. Florell, Kenneth M. Boucher, Nwanneka Okwundu, William J. Burnett, Matthew W. VanBrocklin, Douglas Grossman
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:Pharmaceuticals
Subjects:
aspirin
salicylate
pge<sub>2</sub>
ampk
plasma
nevi
Online Access:https://www.mdpi.com/1424-8247/13/1/7

Internet

https://www.mdpi.com/1424-8247/13/1/7

Similar Items